Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    21300929 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed A Phase 1/2 Study Evaluating ABT-751 in Combination With Alimta in Advanced Non-Small Cell Lung Cancer
Conditions: Lung Cancer;   NSCLC;   Non-Small-Cell Lung Cancer
Interventions: Drug: ABT-751;   Drug: pemetrexed;   Drug: placebo

Indicates status has not been verified in more than two years